Emerald Bioscience (EMBI) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free EMBI Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSprint Bioscience AB SPRINTmorningstar.com - April 19 at 11:36 PMCannabis Bioscience Stock (OTC:CBIH), Quotes and News Summarybenzinga.com - April 16 at 10:22 AMEmerald Bioscience (OTCMKTS:EMBI) Hits New 12-Month High at $14.95marketbeat.com - March 18 at 11:13 PMDaré Bioscience, Inc. (DARE)finance.yahoo.com - February 21 at 2:01 PMStar Lake Bioscience Co. Ltd. Guangdong Zhaoqing Awsj.com - January 17 at 7:44 AMBnp Paribas Easy Jpm Esg Embi Global Diversified Composite Ucits Etf H Eur Cap Share Price (EMBH.PA)lse.co.uk - November 15 at 1:32 PMConstruction starts on $55M senior living project in Redmondbizjournals.com - September 6 at 3:41 AMDuluth takes less aggressive stance against emerald ash borers, prepares to cutduluthnewstribune.com - February 21 at 1:33 AMEmerald Health Therapeutics, Inc. Reports 2022 Q1 Resultsfinance.yahoo.com - July 11 at 8:04 AM Get Emerald Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for EMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> EMBI Media Mentions By Week EMBI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EMBI News Sentiment▼0.000.32▲Average Medical News Sentiment EMBI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EMBI Articles This Week▼10▲EMBI Articles Average Week Get Emerald Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for EMBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sensei Biotherapeutics News Exagen News Bioxytran News Inspira Technologies Oxy B.H.N. News Lipocine News CytoMed Therapeutics News Unity Biotechnology News Cumberland Pharmaceuticals News Cue Health News Lisata Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:EMBI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emerald Bioscience Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
